In particular, the TGFβ inhibitor peptide P144 (derived from the extracellular sequence of the human TGFβ type III receptor) successfully impaired tumor growth and increased survival of nude mice implanted with human glioblastoma xenografts [138]. This evidence concerns the gene TGFB1 and neoplasm.